Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry-Reference-Cited by-同舟云学术

Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry

Published:2020-12 Issue: Volume:31 Page:100666
ISSN:2352-9067
Container-title:IJC Heart & Vasculature
language:en
Short-container-title:IJC Heart & Vasculature

Author:

Dubner Sergio^ORCID,Saraiva José Francisco Kerr,Fragoso Juan Carlos Nunez,Barón-Esquivias Gonzalo^ORCID,Teutsch Christine,Gurusamy Venkatesh Kumar,Marler Sabrina^ORCID,Huisman Menno V.,Lip Gregory Y.H.,Zeballos Cecilia^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study;Lloyd-Jones;Circulation.,2004

2. Burden of disease from atrial fibrillation in adults from seven countries in Latin America;Cubillos;Int. J. Gen. Med.,2014

3. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann. Intern. Med.,2007

4. RealiseAF investigators. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey;Gamra;Arch. Cardiovasc. Dis.,2014

5. Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective;Cantú-Brito;Clin. Appl. Thromb. Hemost.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry;American Journal of Therapeutics;2023-01-10

2. Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials;Frontiers in Cardiovascular Medicine;2022-03-04